How Accurate Is a Calcium Score Test?

A coronary artery calcium (CAC) score test is quite accurate for its intended purpose: predicting your future risk of heart attack and other coronary events. In a large multi-ethnic study, adding the calcium score to traditional risk factors significantly improved risk classification, bumping more people into the correct risk category than conventional formulas alone could manage. But “accurate” depends on what you’re asking the test to do. As a crystal ball for long-term cardiovascular risk, it performs well. As a tool for diagnosing whether you currently have a dangerous blockage, it has real blind spots that are worth understanding before you get scanned.

What the Test Actually Measures

The calcium score test uses a quick, non-contrast CT scan of your chest to detect and quantify calcified plaque in your coronary arteries. The scan takes about ten minutes and requires no dye injection or IV. A computer algorithm assigns a score, commonly using a method called the Agatston score, based on the area and density of calcified deposits it finds. The result is a single number: zero means no detectable calcified plaque, while scores in the hundreds or thousands indicate progressively heavier buildup. The test’s primary role is cardiovascular risk stratification, helping you and your doctor gauge how likely a heart attack or other major coronary event is over the coming years.¹

Accuracy for Predicting Future Heart Events

This is where the calcium score shines. The Multi-Ethnic Study of Atherosclerosis (MESA), one of the largest and longest-running studies on the topic, found that adding the calcium score to a prediction model built on traditional risk factors (blood pressure, cholesterol, smoking, diabetes, age) significantly improved the classification of who was actually at risk. The net reclassification improvement was 0.25, meaning the calcium score correctly moved a substantial share of people into more appropriate risk categories compared to using standard risk factors alone.² That might sound abstract, but in practical terms it means a meaningful number of people who would have been told “you’re fine” by a standard calculator were correctly flagged as higher risk, and vice versa.

A separate review compiling multiple studies confirmed that the calcium score serves as a reliable indicator of coronary artery disease and concluded that combining age-specific risk analysis with CAC scoring can help direct treatment and prevent deaths in people who have no symptoms.³ The test is especially useful for people in the so-called “borderline” or “intermediate” risk zone, where standard calculators leave doctors uncertain about whether to start treatment.

The Meaning of a Zero Score

A calcium score of zero is one of the most reassuring results in preventive cardiology, but it is not a guarantee. In a prospective study of nearly 10,000 asymptomatic people, a score of zero was associated with a “warranty period” of close to 15 years for those at low to intermediate risk, meaning the chance of a fatal coronary event stayed very low for that long.⁴ A more detailed MESA analysis refined this, finding that the warranty period before calcium appeared varied from roughly 3 to 7 years depending on sex and race, and that about 19% of all coronary events over a decade occurred in people whose last scan had shown zero calcium.⁵

That 19% figure is the key nuance. A zero score dramatically lowers your near-term risk, but it doesn’t eliminate it entirely. Diabetes, in particular, shortened the warranty period significantly. If you have diabetes and a zero score, you may not stay in the clear as long as someone without it.

The Soft Plaque Blind Spot

The calcium score test can only see calcified plaque. It is completely blind to so-called “soft” or noncalcified plaque, which is actually the type most prone to rupturing and causing a sudden heart attack. In a study of 447 symptomatic patients who all had a calcium score of zero, about one in ten turned out to have noncalcified plaque on CT angiography, and four of those patients had blockages exceeding 50%.⁶ A study from Pakistan found an even higher rate: roughly 29% of symptomatic patients with zero calcium scores had some degree of soft plaque disease, and about 6% had obstructive blockages.⁷

The difference between these two studies likely reflects the populations involved: one looked at a general symptomatic group while the other focused on South Asian patients, who tend to develop heart disease earlier and through different patterns. But the takeaway is consistent. If you are having active chest pain or other cardiac symptoms, a zero calcium score does not rule out dangerous plaque. Your doctor will likely want further testing, such as CT angiography or a stress test, rather than relying on the calcium score alone.

How It Compares to CT Angiography

CT angiography (CTA) uses contrast dye to visualize both calcified and noncalcified plaque, giving a much more complete picture of what is happening inside the arteries. In a large meta-analysis pooling individual patient data from multiple centers, CT angiography had a diagnostic accuracy of about 81% for detecting obstructive coronary artery disease, compared to roughly 69% for the calcium score alone. Among patients with a calcium score of zero, 17% turned out to have obstructive disease on angiography.⁸

An occupational health study of aviation workers illustrated this gap from a different angle. Using the calcium score pathway led to more than double the number of people being cleared for full employment compared to using CTA. That sounds like an advantage until you learn that about 12% of those cleared by calcium scoring would have been flagged for significant noncalcified plaque disease on CTA.⁹ In high-stakes occupational settings like aviation, that gap matters. For routine screening of asymptomatic people, the calcium score’s lower radiation dose and lower cost make it the more practical first-line tool, with CTA reserved for cases where more information is needed.

When a NICE-Style Staged Approach Works Best

A UK district hospital audit evaluated the strategy recommended by the UK’s National Institute for Health and Care Excellence (NICE): use the calcium score first, then follow up with CTA or invasive angiography only if the score is positive. This staged approach yielded a sensitivity of 88% and a specificity of 94%, with a negative predictive value of 98%.¹⁰ In other words, when the calcium score was used as a gatekeeper rather than a standalone diagnostic tool, very few cases slipped through. A 98% negative predictive value means that if the staged workup says you’re clear, there is only about a 2% chance something was missed.

Research on combining calcium scoring with exercise treadmill testing tells a similar story. Adding the calcium score to standard treadmill results dramatically improved the ability to detect obstructive coronary disease, reaching a performance level comparable to more expensive stress imaging with nuclear tracers.¹¹ The calcium score, used as one piece of a puzzle rather than the whole answer, performs well.

How It Changes Treatment Decisions

One of the most concrete ways to evaluate a test’s accuracy is to ask whether it changes what doctors do, and whether those changes make sense. In a randomized feasibility trial, using calcium scores to guide statin prescriptions reclassified about one in five patients compared to using a standard risk calculator. Roughly 36% of people who would have been put on a statin were taken off, and about 6% who would not have been offered one started treatment instead.¹² A separate analysis of borderline-risk patients found that 21 to 35% of those classified as borderline by standard calculators actually had calcium scores above 100, bumping them into a higher risk category that warranted more aggressive prevention.¹³

Clinicians respond to calcium scores in their prescribing patterns, too. In one study, a score above 100 was associated with roughly a six-fold increase in the odds that a clinician would start antiplatelet therapy, while a score above 100 was independently associated with a 31-fold increase in statin prescriptions compared to a score of zero.¹⁴

Diagnostic Accuracy at a Specific Cutoff

Using a cutoff score of 100, one study found the calcium score had a sensitivity of 79% and a specificity of 87% for detecting significant coronary stenosis, with an overall accuracy of 84%.¹⁵ Those are solid numbers for a quick, low-radiation scan, but they also mean about one in five significant blockages were missed (the 21% who had disease but scored below 100), and about 13% of people flagged did not actually have significant disease. This is why cardiologists treat the calcium score as a risk-stratification tool rather than a diagnostic one. It helps sort people into the right lanes for further testing, not replace that testing.

Age, Sex, and Ethnicity Influence the Numbers

Your calcium score does not exist in a vacuum. What counts as “high” depends heavily on your age and sex. Men accumulate coronary calcium earlier and faster than women, and scores increase with age in both groups, though the pattern differs: men show a more gradual, decelerating curve while women show an accelerating one.¹⁶ Percentile-based reference charts exist to help compare your score to others of the same age and sex, but a pooled analysis found that the existing widely used charts can differ from updated weighted calculations by as much as 24%.¹⁷

Ethnicity also matters. The MESA study found that the prevalence of any detectable calcium varied substantially across racial groups even after adjusting for traditional risk factors. White men had the highest prevalence at about 70%, compared to roughly 52% in Black men, 57% in Hispanic men, and 59% in Chinese American men. Women followed a similar pattern at lower overall rates.¹⁸ Despite these baseline differences, the predictive value of the calcium score held up across all four groups: a doubling of the score increased the risk of a major coronary event by 15 to 35%, with no major difference in accuracy between racial or ethnic groups.¹⁹ The test works across populations, but absolute scores need to be interpreted in context.

The Statin Paradox

Here is something that confuses both patients and some doctors: statin medications can make your calcium score go up over time, even while they are protecting your heart. A study found that longer statin use was associated with progressively higher odds of having elevated calcium scores, with over ten years of statin therapy linked to roughly four and a half times the odds of a higher score after adjusting for other risk factors.²⁰

But this is not the danger signal it appears to be. Research using detailed CT imaging found that statins shift the character of plaque toward denser, more stable calcification rather than increasing overall plaque volume. The soft, rupture-prone components of plaque shrink, while the hard, stable calcium component increases.²¹ A narrative review synthesizing the available evidence confirmed that while statins promote plaque calcification on imaging, this densification is actually associated with greater plaque stability and fewer heart attacks and strokes.²²

The practical takeaway: if you are already on a statin, a rising calcium score on a follow-up scan does not necessarily mean your heart disease is getting worse. In fact, it may be a sign the medication is doing its job. This makes serial calcium scoring in statin users harder to interpret, and it’s one reason many guidelines recommend using the first scan for decision-making rather than tracking changes over time in people already on treatment.

Tracking Changes Over Time

For people not on statins, serial calcium scoring can provide useful information. A meta-analysis found that an annualized calcium score increase of more than 20 units per year significantly predicted death from all causes, suggesting that the rate of change carries prognostic weight beyond what a single snapshot provides.²³ For someone whose initial score was zero, the MESA data suggest that developing new detectable calcium preceded the majority of future coronary events and identified people at three-fold higher risk.⁵ The statin caveat discussed above complicates this picture, but for untreated patients, progression is a meaningful warning signal.

Radiation Exposure in Perspective

The calcium score scan involves a small dose of radiation. Using modern scanners, the effective dose averages about 1 millisievert (mSv), roughly comparable to a few months of natural background radiation or a mammogram.²⁴ An earlier analysis using older protocols found a wider range, from 0.8 to 10.5 mSv depending on the scanner and settings, and estimated that repeated screening every five years from middle age onward would carry a cumulative radiation-induced cancer risk of roughly 42 to 62 per 100,000 people.²⁵ With current-generation scanners, the dose is consistently at the low end of that range, making the radiation risk small in absolute terms, though not zero.

What Else the Scan Might Find

Because the calcium score scan images a slice of your chest, it sometimes catches things unrelated to your heart. In one prospective study, about 36% of patients had incidental findings that led to further investigation.²⁶ The most common incidental findings include lung nodules (especially in smokers and older adults), liver cysts, pleural effusions, and breast calcifications.²⁷ Most of these turn out to be benign, but they can trigger follow-up imaging, additional anxiety, and sometimes useful early detection of conditions like lung cancer. It’s a mixed bag: you might learn something valuable about your lungs, or you might spend months tracking a harmless nodule before it’s declared a non-issue.

The Motivational Effect of Seeing Your Score

One underappreciated dimension of the calcium score’s “accuracy” is whether it changes behavior in a way that prevents future disease. And the evidence here is surprisingly consistent: seeing a high number makes people take their health more seriously. In one study, aspirin use was only 29% among people with a zero score but climbed to 63% among those scoring 400 or higher. Dietary changes followed the same gradient, from 33% with a zero score to 56% with scores above 400.²⁸ A separate study found the same dose-response pattern for statin adherence: only about 27% of people with a zero score stayed on their statins, compared to nearly 59% of those with scores above 400.²⁹

There is a flip side worth noting. Some trials have failed to show that providing calcium score results changes behavior at all.³⁰ And the lower adherence rates among people with zero scores raise a legitimate concern: being told your score is zero might make you feel invincible and less likely to follow through on lifestyle changes or prescribed medications, even if other risk factors still warrant them.

AI-Automated Scoring From Existing Scans

A growing area of research involves using artificial intelligence to extract calcium scores from CT scans that were performed for other reasons, like lung cancer screening or trauma evaluation. Deep learning models, especially convolutional neural networks, have shown high agreement with manual scoring by radiologists in multiple studies.³¹ This is a meaningful development because millions of chest CTs are performed each year for non-cardiac reasons, and each of those scans contains coronary arteries that go unexamined. Automated calcium scoring could flag people at elevated cardiac risk without requiring an additional scan, additional radiation, or an additional appointment. The technology is not yet standard clinical practice, but it represents a likely near-term expansion of who benefits from calcium scoring.

A cost-effectiveness analysis found that performing a full chest CT calcium scan (rather than the conventional limited cardiac scan) during lung cancer screening added only a modest incremental cost while picking up additional clinically relevant findings.³² As AI makes it easier to pull cardiac data from non-cardiac scans, the line between a dedicated calcium score test and an opportunistic one is blurring.

Cost and Who Should Get One

In many countries, the calcium score test is not covered by insurance for routine screening, and out-of-pocket costs typically run between $50 and $300 depending on the facility. A Canadian cost-effectiveness analysis found that using calcium scores to guide statin prescriptions was cost-effective at the 10-year horizon, costing about $8,100 per quality-adjusted life-year gained compared to giving statins to everyone who qualified on a risk calculator.³³ An older U.S. analysis raised the point that screening all 10,000 eligible women to find the 2,500 with calcium above zero would provide only 45% of the total possible benefit from statins at a cost of $2.25 million and a projected 9 radiation-induced cancers.³⁴ The economics shift favorably as scanner radiation doses drop and as AI-driven opportunistic scoring emerges, but for now the test makes the most financial and clinical sense for people in the borderline risk range where the result is most likely to change a treatment decision.